Department of Clinical Immunology, Laboratory of Immunogenetics and Tissue Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wrocław, Poland.
Department of Gynecology and Gynecologic Oncology, Polish Mothers' Memorial Hospital-Research Institute, Rzgowska 281/289, 93-338, Łódź, Poland.
Arch Immunol Ther Exp (Warsz). 2017 Oct;65(5):391-399. doi: 10.1007/s00005-017-0474-6. Epub 2017 May 18.
Reproductive failure in humans is a very important social and economic problem, because nowadays women decide to conceive later in life and delay motherhood. Unfortunately, with increasing age they have less chance for natural fertilization and maintenance of pregnancy. Many of them need assisted reproductive technology. Approximately 10% of women after in vitro fertilization-embryo transfers experience recurrent implantation failure (RIF). Multiple factors may contribute to RIF, including oocyte and sperm quality, parental chromosomal anomalies, genetic or metabolic abnormalities of the embryo, poor uterine receptivity, immunological disturbances in the implantation site, and some gynecologic pathologies such as endometriosis, uterine fibroids, hydrosalpinx and endometrial polyps. Moreover, the procedure of in vitro fertilization itself could adversely influence the implantation. Nowadays, many studies are focused on the role of natural killer (NK) cells in normal and pathologic pregnancy because NK cells constitute the dominant cell population in the endometrium and they come in close contact with the allogeneic extravillous trophoblast cells in early pregnancy decidua. The majority of these cells are of CD56 phenotype. These cells can express killer immunoglobulin-like receptors (KIRs), which, upon recognition of HLA class I molecules (HLA-C and HLA-G) on trophoblasts, may either stimulate or inhibit NK cells to produce soluble factors, and display low cytotoxicity necessary for maintenance of the allogeneic embryo and fetus in the next steps of pregnancy. Moreover, some members of the leukocyte immunoglobulin-like receptor (LILR) family, also named ILT (immunoglobulin-like transcript), are present in the human placenta. LILRB1 (ILT2) was described mainly on stromal cells, while LILRB2 (ILT4), in addition to stromal cells, was also found around vessels in the smooth muscle layer. In this review we focus on the possible role of polymorphism of KIR, LILRB and their ligands (HLA-C, HLA-G) in susceptibility to recurrent implantation failure, which could serve as diagnostic biomarkers of this disease.
人类生殖失败是一个非常重要的社会和经济问题,因为现在女性决定晚育,延迟生育。不幸的是,随着年龄的增长,她们自然受精和维持妊娠的机会减少。她们中的许多人需要辅助生殖技术。大约 10%的体外受精-胚胎移植后患者经历反复着床失败(RIF)。RIF 的发生可能与多个因素有关,包括卵母细胞和精子质量、父母染色体异常、胚胎遗传或代谢异常、子宫容受性差、着床部位免疫紊乱以及子宫内膜异位症、子宫肌瘤、输卵管积水和子宫内膜息肉等一些妇科疾病。此外,体外受精本身的过程也可能对着床产生不利影响。如今,许多研究都集中在自然杀伤(NK)细胞在正常和病理妊娠中的作用上,因为 NK 细胞构成了子宫内膜中的主要细胞群体,并且在早孕蜕膜中与同种异体的绒毛外滋养层细胞密切接触。这些细胞中的大多数为 CD56 表型。这些细胞可以表达杀伤细胞免疫球蛋白样受体(KIR),当识别滋养细胞上的 HLA Ⅰ类分子(HLA-C 和 HLA-G)时,这些受体可以刺激或抑制 NK 细胞产生可溶性因子,并显示出维持妊娠下一阶段同种异体胚胎和胎儿所必需的低细胞毒性。此外,白细胞免疫球蛋白样受体(LILR)家族的一些成员,也称为 ILT(免疫球蛋白样转录物),存在于人类胎盘上。LILRB1(ILT2)主要存在于基质细胞中,而 LILRB2(ILT4)除了基质细胞外,还存在于平滑肌层的血管周围。在这篇综述中,我们重点介绍了 KIR、LILRB 及其配体(HLA-C、HLA-G)的多态性在易感性反复着床失败中的可能作用,这可以作为该疾病的诊断生物标志物。